Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
This is a once-in-a-generation opportunity to shape not just a drug market, but a healthcare paradigm
Ready to Explore PT-141 Peptide Therapy
GLP-1 medications deliver substantially greater weight loss: semaglutide trials showed 1015% body weight reduction over 68 weeks, and tirzepatide (a dual GLP-1/GIP agonist) demonstrated 20%+ reductions in some cohorts
New patients require an initial consultation
US$ 26.11
US$ 29.22
US$ 29.33
US$ 23.90
US$ 28.55
US$ 28.17
US$ 24.36
US$ 29.17
US$ 22.92
